Imaging of Valvular Heart Disease

Canadian Journal of Cardiology

Volumn 29, Issue 3, 2013, Pages 337-349

  Pibarot, Philippe ^a   Larose, Éric ^a   Dumesnil, Jean ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD FLOW; BLOOD PRESSURE; CALCIFICATION; CARDIAC IMAGING; CLINICAL ASSESSMENT; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DOPPLER ECHOCARDIOGRAPHY; HEART ATRIUM; HEART FUNCTION; HEART LEFT ATRIUM; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HEART RIGHT VENTRICLE; HEART VALVE REGURGITATION; HEART VALVE STENOSIS; HUMAN; MITRAL VALVE REGURGITATION; MOLECULAR IMAGING; MULTIDETECTOR COMPUTED TOMOGRAPHY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PULMONARY HYPERTENSION; REVIEW; STRESS; TRANSCATHETER AORTIC VALVE IMPLANTATION; VALVULAR HEART DISEASE; VIRTUAL REALITY;

CARDIAC IMAGING TECHNIQUES; CORONARY ANGIOGRAPHY; DIAGNOSTIC IMAGING; ECHOCARDIOGRAPHY, DOPPLER; ECHOCARDIOGRAPHY, STRESS; ECHOCARDIOGRAPHY, THREE-DIMENSIONAL; HEART VALVE DISEASES; HEART VENTRICLES; HUMANS; MAGNETIC RESONANCE IMAGING; MULTIDETECTOR COMPUTED TOMOGRAPHY; PRACTICE GUIDELINES AS TOPIC; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY;

EID: 84874335746     PISSN: 0828282X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cjca.2012.11.006     Document Type: Review

References (59)

1. Iung B., Vahanian A. Epidemiology of valvular heart disease in the adult. Nat Rev Cardiol 2011, 8:162-172.
2. Bonow R.O., Carabello B.A., Kanu C., et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2006, 114:e84-e231.
3. Vahanian A., Alfieri O., Andreotti F., et al. Guidelines on the management of valvular heart disease (version 2012): The Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 2012, 33:2451-2496.
4. Baumgartner H., Hung J., Bermejo J., et al. Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice. J Am Soc Echocardiogr 2009, 22:1-23.
5. Pibarot P., Dumesnil J.G. Improving assessment of aortic stenosis. J Am Coll Cardiol 2012, 60:169-180.
6. Zoghbi W.A., Chambers J.B., Dumesnil J.G., et al. Recommendations for evaluation of prosthetic valves with echocardiography and doppler ultrasound: a report From the American Society of Echocardiography's Guidelines and Standards Committee and the Task Force on Prosthetic Valves. J Am Soc Echocardiogr 2009, 22:975-1014.
7. Garcia D., Pibarot P., Dumesnil J.G., Sakr F., Durand L.G. Assessment of aortic valve stenosis severity: a new index based on the energy loss concept. Circulation 2000, 101:765-771.
8. Thavendiranathan P., Liu S., Datta S., et al. Automated quantification of mitral inflow and aortic outflow stroke volumes by three-dimensional real-time volume color-flow Doppler transthoracic echocardiography: comparison with pulsed-wave Doppler and cardiac magnetic resonance imaging. J Am Soc Echocardiogr 2012, 25:56-65.
9. Lang R.M., Tsang W., Weinert L., Mor-Avi V., Chandra S. Valvular heart disease: the value of 3-dimensional echocardiography. J Am Coll Cardiol 2011, 58:1933-1944.
10. Pibarot P., Dumesnil J.G. Low-flow, low-gradient aortic stenosis in normal and depressed left ventricular ejection fraction. J Am Coll Cardiol 2012, 60:1845-1853.
11. deFilippi C.R., Willett D.L., Brickner E., et al. Usefulness of dobutamine echocardiography in distinguishing severe from nonsevere valvular aortic stenosis in patients with depressed left ventricular function and low transvalvular gradients. Am J Cardiol 1995, 75:191-194.
12. Feuchtner G.M., Muller S., Bonatti J., et al. Sixty-four slice CT evaluation of aortic stenosis using planimetry of the aortic valve area. AJR Am J Roentgenol 2007, 189:197-203.
13. Lancellotti P., Lebois F., Simon M., Tombeux C., Chauvel C., Pierard L.A. Prognostic importance of quantitative exercise Doppler echocardiography in asymptomatic valvular aortic stenosis. Circulation 2005, 112:I377-I382.
14. Maréchaux S., Hachicha Z., Bellouin A., et al. Usefulness of exercise stress echocardiography for risk stratification of true asymptomatic patients with aortic valve stenosis. Eur Heart J 2010, 31:1390-1397.
15. Rosenhek R., Binder T., Porenta G., et al. Predictors of outcome in severe, asymptomatic aortic stenosis. N Engl J Med 2000, 343:611-617.
16. Owens D.S., Budoff M.J., Katz R., et al. Aortic valve calcium independently predicts coronary and cardiovascular events in a primary prevention population. J Am Coll Cardiol 2012, 5:619-625.
17. Cueff C., Serfaty J.M., Cimadevilla C., et al. Measurement of aortic valve calcification using multislice computed tomography: correlation with haemodynamic severity of aortic stenosis and clinical implication for patients with low ejection fraction. Heart 2011, 97:721-726.
18. Sverdlov A.L., Ngo D.T., Chan W.P., et al. Determinants of aortic sclerosis progression: implications regarding impairment of nitric oxide signalling and potential therapeutics. Eur Heart J 2012, 33:2419-2425.
19. Tizon-Marcos H., Larose é., Fuchs C., Mathieu P., Pibarot P., Charest A. Human valve leaflet tissue characterization in severe aortic stenosis. Circulation 2010, 122(Suppl 21):A19916. [abstract]. American Heart Association Scientific Sessions 2010. Chicago, Illinois. November 13-17, 2010.
20. Lancellotti P., Tribouilloy C., Hagendorff A., et al. European Association of Echocardiography recommendations for the assessment of valvular regurgitation. Part 1: aortic and pulmonary regurgitation (native valve disease). Eur J Echocardiogr 2010, 11:223-244.
21. Lancellotti P., Moura L., Pierard L.A., et al. European Association of Echocardiography recommendations for the assessment of valvular regurgitation. Part 2: mitral and tricuspid regurgitation (native valve disease). Eur J Echocardiogr 2010, 11:307-332.
22. Enriquez-Sarano M., Avierinos J.F., Messika-Zeitoun D., et al. Quantitative determinants of the outcome of asymptomatic mitral regurgitation. N Engl J Med 2005, 352:875-883.
23. Detaint D., Messika-Zeitoun D., Maalouf J., et al. Quantitative echocardiographic determinants of clinical outcome in asymptomatic patients with aortic regurgitation: a prospective study. JACC Cardiovasc Imaging 2008, 1:1-11.
24. Magne J., Lancellotti P., Piérard L.A. Exercise-induced changes in degenerative mitral regurgitation. J Am Coll Cardiol 2010, 56:300-309.
25. Marsan N.A., Westenberg J.J., Ypenburg C., et al. Quantification of functional mitral regurgitation by real-time 3D echocardiography: comparison with 3D velocity-encoded cardiac magnetic resonance. JACC Cardiovasc Imaging 2009, 2:1245-1252.
26. Hyodo E., Iwata S., Tugcu A., et al. Direct measurement of multiple vena contracta areas for assessing the severity of mitral regurgitation using 3D TEE. JACC Cardiovasc Imaging 2012, 5:669-676.
27. Lang R.M., Adams D.H. 3D echocardiographic quantification in functional mitral regurgitation. JACC Cardiovasc Imaging 2012, 5:346-347.
28. Cawley P.J., Maki J.H., Otto C.M. Cardiovascular magnetic resonance imaging for valvular heart disease: technique and validation. Circulation 2009, 119:468-478.
29. Jabbour A., Ismail T.F., Moat N., et al. Multimodality imaging in transcatheter aortic valve implantation and post-procedural aortic regurgitation: comparison among cardiovascular magnetic resonance, cardiac computed tomography, and echocardiography. J Am Coll Cardiol 2011, 58:2165-2173.
30. Pierard L.A., Lancellotti P. The role of ischemic mitral regurgitation in the pathogenesis of acute pulmonary edema. N Engl J Med 2004, 351:1627-1634.
31. Buck T., Hwang S.M., Plicht B., et al. Automated flow quantification in valvular heart disease based on backscattered Doppler power analysis: implementation on matrix-array ultrasound imaging systems. Int J Cardiovasc Imaging 2008, 24:463-477.
32. Weidemann F., Herrmann S., Stork S., et al. Impact of myocardial fibrosis in patients with symptomatic severe aortic stenosis. Circulation 2009, 120:577-584.
33. Azevedo C.F., Nigri M., Higuchi M.L., et al. Prognostic significance of myocardial fibrosis quantification by histopathology and magnetic resonance imaging in patients with severe aortic valve disease. J Am Coll Cardiol 2010, 56:278-287.
34. Nazarian S. Is ventricular arrhythmia a possible mediator of the association between aortic stenosis-related midwall fibrosis and mortality?. J Am Coll Cardiol 2011, 58:1280-1282.
35. Mewton N., Liu C.Y., Croisille P., Bluemke D., Lima J.A.C. Assessment of myocardial fibrosis with cardiovascular magnetic resonance. J Am Coll Cardiol 2011, 57:891-903.
36. Dumesnil J.G., Shoucri R.M., Laurenceau J.L., Turcot J. A mathematical model of the dynamic geometry of the intact left ventricle and its application to clinical data. Circulation 1979, 59:1024-1034.
37. Cramariuc D., Cioffi G., Rieck A.E., et al. Low-flow aortic stenosis in asymptomatic patients: valvular arterial impedance and systolic function from the SEAS substudy. JACC Cardiovasc Imaging 2009, 2:390-399.
38. Lancellotti P., Donal E., Magne J., et al. Risk stratification in asymptomatic moderate to severe aortic stenosis: the importance of the valvular, arterial and ventricular interplay. Heart 2010, 96:1364-1371.
39. Cramariuc D., Gerdts E., Davidsen E.S., Segadal L., Matre K. Myocardial deformation in aortic valve stenosis - relation to left ventricular geometry. Heart 2009, 96:106-112.
40. Delgado V., Tops L.F., van Bommel R.J., et al. Strain analysis in patients with severe aortic stenosis and preserved left ventricular ejection fraction undergoing surgical valve replacement. Eur Heart J 2009, 30:3037-3047.
41. Monin J.L., Quere J.P., Monchi M., et al. Low-gradient aortic stenosis: operative risk stratification and predictors for long-term outcome: a multicenter study using dobutamine stress hemodynamics. Circulation 2003, 108:319-324.
42. Lee R., Haluska B., Leung D.Y., Case C., Mundy J., Marwick T.H. Functional and prognostic implications of left ventricular contractile reserve in patients with asymptomatic severe mitral regurgitation. Heart 2005, 91:1407-1412.
43. Le Tourneau T., Messika-Zeitoun D., Russo A., et al. Impact of left atrial volume on clinical outcome in organic mitral regurgitation. J Am Coll Cardiol 2010, 56:570-578.
44. Dalsgaard M., Egstrup K., Wachtell K., et al. Left atrial volume in patients with asymptomatic aortic valve stenosis (the Simvastatin and Ezetimibe in Aortic Stenosis study). Am J Cardiol 2008, 101:1030-1034.
45. Magne J., Lancellotti P., Pierard L.A. Exercise pulmonary hypertension in asymptomatic degenerative mitral regurgitation. Circulation 2010, 122:33-41.
46. Lancellotti P., Magne J., Donal E., et al. Determinants and prognostic significance of exercise pulmonary hypertension in asymptomatic severe aortic stenosis. Circulation 2012, 126:851-859.
47. Kempny A., Diller G.P., Kaleschke G., et al. Impact of transcatheter aortic valve implantation or surgical aortic valve replacement on right ventricular function. Heart 2012, 98:1299-1304.
48. Delgado V., Kapadia S., Marsan N.A., Schalij M.J., Tuzcu E.M., Bax J.J. Multimodality imaging before, during, and after percutaneous mitral valve repair. Heart 2011, 97:1704-1714.
49. Delgado V., Kapadia S., Schalij M.J., Schuijf J.D., Tuzcu E.M., Bax J.J. Transcatheter aortic valve implantation: implications of multimodality imaging in patient selection, procedural guidance, and outcomes. Heart 2012, 98:743-754.
50. Bloomfield G.S., Gillam L.D., Hahn R.T., et al. A practical guide to multimodality imaging of transcatheter aortic valve replacement. JACC Cardiovasc Imaging 2012, 5:441-455.
51. Goncalves A., Almeria C., Marcos-Alberca P., et al. Three-dimensional echocardiography in paravalvular aortic regurgitation assessment after transcatheter aortic valve implantation. J Am Soc Echocardiogr 2012, 25:47-55.
52. Larose E., Yeghiazarians Y., Libby P., et al. Characterization of human atherosclerotic plaques by intravascular magnetic resonance imaging. Circulation 2005, 112:2324-2331.
53. Aikawa E., Nahrendorf M., Sosnovik D., et al. Multimodality molecular imaging identifies proteolytic and osteogenic activities in early aortic valve disease. Circulation 2007, 115:377-386.
54. Dweck M.R., Jones C., Joshi N.V., et al. Assessment of valvular calcification and inflammation by positron emission tomography in patients with aortic stenosis. Circulation 2012, 125:76-86.
55. Marincheva-Savcheva G., Subramanian S., Qadir S., et al. Imaging of the aortic valve using fluorodeoxyglucose positron emission tomography increased valvular fluorodeoxyglucose uptake in aortic stenosis. J Am Coll Cardiol 2011, 57:2507-2515.
56. Hyafil F., Messika-Zeitoun D., Burg S., et al. Detection of (18)fluoride sodium accumulation by positron emission tomography in calcified stenotic aortic valves. Am J Cardiol 2012, 109:1194-1196.
57. Yedidya I., Stein G.Y., Vaturi M., et al. Positron emission tomography/computed tomography for the diagnosis of endocarditis in patients with pulmonic stented valve/pulmonic stent. Ann Thorac Surg 2011, 91:287-289.
58. Hope M.D., Hope T.A., Meadows A.K., et al. Bicuspid aortic valve: four-dimensional MR evaluation of ascending aortic systolic flow patterns. Radiology 2010, 255:53-61.
59. Markl M., Kilner P.J., Ebbers T. Comprehensive 4D velocity mapping of the heart and great vessels by cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2011, 13:7.